Measurement of eicosanoids in cancer tissues.

Measurement of eicosanoids in cancer tissues. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Measurement of eicosanoids in cancer tissues. Abstract Text:

Dingzhi Wang,Raymond N DuBois,Dingzhi Wang,Raymond N DuBois,

Eicosanoids derived from arachidonic acid through cyclooxygenase (COX), lipoxygenase (LOX), and P450 pathways include prostanoids, hydroxyeicosatetraenoic acids (HETEs), leukotrienes (LTs), and epoxyeicosatrienoic acids (EETs). These bioactive lipids play an important role in regulating cell proliferation, apoptosis, tissue repair, blood clotting, blood vessel permeability, inflammation, and immune cell behavior. Moreover, some of these eicosanoids also modulate inflammation and tumor growth in cancer tissues, and may serve as biomarkers for monitoring colorectal cancer progression or as an intermediate marker for the pharmacologic activity of chemopreventive agents. Development of sensitive, rapid, and specific methods for determining eicosanoid levels accurately will facilitate an understanding of the biologic functions of these lipid mediators and will broaden our insight of the importance of these bioactive lipids in vivo. However, quantitative determination of eicosanoids in biological samples has presented a problem to many investigators. It is necessary to understand the advantages and limitations of each method for quantitative analysis of specific eicosanoids in various types of biological samples. Here we evaluate the methodology of the measurement of eicosanoids in biological samples.

Measurement of eicosanoids in cancer tissues. Publishing Authors By Initials

D Wang,RN DuBois,D Wang,RN DuBois,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Measurement of eicosanoids in cancer tissues. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Methods in enzymology

VOLUME: 433

Page Numbers: 27-50

Journal Abbreviation: Meth. Enzymol.

ISSN: 0076-6879

DAY: 23

MONTH: 10

YEAR: 2007

Measurement of eicosanoids in cancer tissues. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 212271

Measurement of eicosanoids in cancer tissues. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Measurement of eicosanoids in cancer tissues. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Measurement of eicosanoids in cancer tissues.

AFFILIATION: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Country: United States

AGENCY: United States NIDDK

GRANT: R37-DK47297

ACRONYM: DK

MEDLINETA: Methods Enzymol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Measurement of eicosanoids in cancer tissues Related Publications

• A biomechanical model of the pelvic cavity: first steps.
• A novel approach to clinical-radiological correlations: Anatomo-Clinical Overlapping Maps (AnaCOM): method and validation.
• A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch.
• Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
• Benchmarking in the eighteenth century.
• Bungendore health impact assessment: urban development in a rural setting.
• Clinical diagnostic criteria for dementia associated with Parkinson's disease.
• Cross-border referral for early breast cancer: an analysis of radiation fractionation patterns.
• Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.
• Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: A guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
• Direction of persistent ischemic mitral jet after restrictive valve annuloplasty: Implication for interpretation of perioperative echocardiography.
• Effects of acute exposure to aluminum on cognition in humans.
• Encephalitis following Mycoplasma pneumonia (2007: 6b). Acute disseminated encephalomyelitis.
• Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.
• High pretransplantation soluble CD30 levels: impact in renal transplantation.
• Hypoxia-inducible Factor Mediates Hypoxic and Tumor Necrosis Factor {alpha}-induced Increases in Tumor Necrosis Factor-{alpha} Converting Enzyme/ADAM17 Expression by Synovial Cells.
• Is PD-MCI a useful concept?
• Measurement of eicosanoids in cancer tissues.
• NSAIDs and cancer prevention: targets downstream of COX-2.
• Noninvasive cardiac output monitoring (NICOM): a clinical validation.
• Oxybutynin extended release and tolterodine immediate release : a health economic comparison.
• Polarization-sensitive full-field optical coherence tomography.
• Pure topographical disorientation following a right forceps major of the splenium lesion: a case study.
• Ras up-regulation of cyclooxygenase-2.
• Synthesis and biological evaluation of potential bisubstrate inhibitors of protein farnesyltransferase. Design and synthesis of functionalized imidazoles.
• Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
• The needs of rural and urban young, middle-aged and older adults with a serious mental illness.
• Thiol-disulphide oxidoreductase modules in the low-GC Gram-positive bacteria.
• [Frontotemporal dementia]
• [In Process Citation]